apollo
logo
0
  1. Home
  2. Medicine
  3. Glycomet 1 GM Tablet 15's
  4. Health Queries for Glycomet 1 GM Tablet 15's
  5. For a 65-year-old patient with a 10-year history of type 2 diabetes who exhibits persistent hyperglycemia (fasting blood sugar of 141 mg/dL and postprandial blood sugar of 279 mg/dL) despite dietary adherence and a multi-drug regimen of metformin, glimepiride, pioglitazone, and voglibose, what pharmacological adjustments, alternative medications, or combination therapies should be considered to safely optimize glycemic control?

health query

Have a query?

For a 65-year-old patient with a 10-year history of type 2 diabetes who exhibits persistent hyperglycemia (fasting blood sugar of 141 mg/dL and postprandial blood sugar of 279 mg/dL) despite dietary adherence and a multi-drug regimen of metformin, glimepiride, pioglitazone, and voglibose, what pharmacological adjustments, alternative medications, or combination therapies should be considered to safely optimize glycemic control?

Asked by Female, 65 · 8 days ago

I understand how frustrating it can be when you are doing everything right with your diet and medications, yet your blood sugars remain high. Since you are already taking several oral medications, your body may need a different approach to safely manage this. We might consider simplifying your regimen by introducing modern options, such as a glucagon-like peptide-1 (GLP-1) receptor agonist or starting a gentle dose of insulin to help target those high numbers after meals. Please share these options with your doctor so they can safely customize a plan that keeps you feeling your best.
user icon

Ask Apollo

AI powered Health Chatbot

For a 65-year-old patient with a 10-year history of type 2 diabetes who exhibits persistent hyperglycemia (fasting blood sugar of 141 mg/dL and postprandial blood sugar of 279 mg/dL) despite dietary adherence and a multi-drug regimen of metformin, glimepiride, pioglitazone, and voglibose, what pharmacological adjustments, alternative medications, or combination therapies should be considered to safely optimize glycemic control?

Answered 8 days ago

Related Questions

For a 65-year-old patient with a 10-year history of type 2 diabetes who exhibits persistent hyperglycemia (fasting blood sugar of 141 mg/dL and postprandial blood sugar of 279 mg/dL) despite dietary adherence and a multi-drug regimen of metformin, glimepiride, pioglitazone, and voglibose, what pharmacological adjustments, alternative medications, or combination therapies should be considered to safely optimize glycemic control? | Apollo Pharmacy